Latest News and Press Releases
Want to stay updated on the latest news?
-
Kearny, NJ, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Hugo Neu Corporation today announced the appointment of Michael Meyer as President of Hugo Neu Realty Management, recognizing his longstanding...
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark, 10 February 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
-
Bagsværd, Denmark, 9 February 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
-
Novo Nordisk has filed a lawsuit against telehealth firm Hims & Hers for patent infringement and putting patients’ lives at stake with knockoff drugs.
-
Telenor går inn i 2026 med sterk nordisk vekst, solid finansiell posisjon og en forenklet portefølje, i tråd med ambisjonene fra kapitalmarkedsdagen. – Resultatene for 2025 viser at vi leverer som...
-
Telenor enters 2026 with strong Nordic growth, a solid financial position, and a simplified portfolio in line with the ambitions presented at the Capital Markets Day. “The results for 2025 show that...
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark, 5 February 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
-
The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safet
-
Novo Nordisk A/S has filed its Annual Report 2025 on Form 20-F for the financial year 2025 with the US Securities and Exchange Commission
-
Bagsværd, Denmark, 4 February 2026 –The execution of Novo Nordisk A/S’ overall share repurchase programme for 2026 of up to DKK 15 billion will be initiated on 4 February 2026. As part of this, Novo...